Public Title Status Last Date Modified
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney Disease . . . Completed 20 Jan 2021
A Study to evaluate the efficacy and safety of dapirolizumab pegol in study participants with moderately to severely active systemic lupus erythematosus . . . Ongoing 06 Sep 2021
A study to evaluate the performance of a thermistor-based device to measure respiratory rate Ongoing 30 Nov -0001
A study to test whether different doses of BI 690517 alone or in combination with empagliflozin improve kidney function in people with chronic kidney disease . . . Pending 19 Jan 2022
A Three-Arm, Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Safety and Efficacy of Once-Daily and Twice-Daily Dosing of a Novel Hydrocortisone Acetate 90 mg Suppository For . . . Ongoing 06 Jul 2020
A Two-Part, Open-Label, Randomized, Phase II/III Study of Dinutuximab and Irinotecan versus Irinotecan for Second Line Treatment of Subjects with Relapsed or Refractory Small Cell Lung Cancer . . . Completed 10 Jun 2020
ACTIV-2: Adapt Out COVID Ongoing 30 Nov -0001
An adaptive seamless randomized, double-blind, placebo controlled, dose ranging study to investigate the efficacy and safety of LNP023 in primary IgA nephropathy patients . . . Terminated 20 May 2021
An Adaptive, Randomized, Double-blinded, Placebo-controlled Phase II/III Trial of Monoclonal Antibody SCTA01 Against SARS-CoV-2 in High-Risk Outpatients With COVID-19 (MAOP3 Trial) . . . Ongoing 20 Dec 2021
An Adaptive, Randomized, Double-blinded, Placebo-controlled, Phase II/III Trial of Monoclonal Antibody SCTA01 Against SARS-CoV-2 in Patients With Severe COVID-19 Admitted to High Dependence or Inten . . . Terminated 17 Nov 2021
An exploratory maintenance trial of BI 655064 in patients with lupus nephritis Ongoing 06 May 2021
An Extended Access Program to Assess Long-Term Safety of Bardoxolone Methyl in Patients with Pulmonary Hypertension . . . Terminated 09 Jun 2021
An extension study to provide treatment with Herceptin® or TX05 and assess continued safety and immunogenicity in subjects with HER2-positive early breast cancer following core study TX05-03. . . . Ongoing 16 Jul 2020
An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients with Open Angle Glaucoma or Ocular Hypertension . . . Ongoing 18 Jan 2022
An immunotherapy and a device used together to treat women with precancerous cells on the cervix caused by human papillomavirus (HPV) . . . Completed 22 Oct 2021
An international, multicentre, observational, prospective, longitudinal cohort study to assess the impact of integrated upper limb spasticity management including the use of bont-A injections on patie . . . Completed 15 Jun 2020
An International, Observational, Prospective Study on Long-term Response to Botulinum toxin type A (BoNT-A) Injections in Subjects Suffering from Idiopathic Cervical Dystonia (CD) - Pharmacoeconomic I . . . Completed 27 Aug 2019
An Open-Label, comparative, single dose, clinical phase 1 study to assess the safety and tolerability of Typhiod Conjugate Vaccine (EuTCV) in Healthy adults . . . Completed 02 Aug 2019
An Open-Label, Non-Randomized, Multi-Center Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in the Treatment of Paroxysmal Nocturnal Hemoglubinuria (PNH) . . . Ongoing 25 Jun 2021
Application of Stem Cells for Diabetic Foot Wounds Ongoing 09 Jul 2019
ARISE: A multi-center prospective non-interventional study investigating the clinical effectiveness of Ryzodeg® (Insulin Degludec/Insulin Aspart) in patients with type 2 diabetes mellitus in a real w . . . Completed 06 May 2021
Avigan Trial Ongoing 11 Sep 2020
B-Clear Study Ongoing 24 Sep 2020
BEe-HIVe Ongoing 30 Nov -0001
©2022 HERDIN PLUS. All rights reserved. | Contact Us | Keep up to date